Skip to content
MarketScale
‹ Back to IndustriesHealthcare

5 Non-Surgical Treatment Options for Carpal Tunnel

In recent decades, carpal tunnel syndrome (CTS) has become far more prevalent.1 CTS is now the most common neuropathic compression syndrome of the upper limbs. Symptoms of carpal tunnel syndrome include pain, weakness, numbness, and tingling in the hand and arm. Typically, carpal tunnel syndrome begins as a minor inconvenience, but gets progressively worse over time,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

In recent decades, carpal tunnel syndrome (CTS) has become far more prevalent.1 CTS is now the most common neuropathic compression syndrome of the upper limbs. Symptoms of carpal tunnel syndrome include pain, weakness, numbness, and tingling in the hand and arm. Typically, carpal tunnel syndrome begins as a minor inconvenience, but gets progressively worse over time, so early diagnosis and treatment are essential. The carpal tunnel is a narrow, rigid passage in the wrist, about an inch wide, formed by small bones called the carpal bones and a strong band of connective tissue called the transverse carpal ligament.2The median nerve—which provides feeling in the thumb and index, middle, and ring fingers—begins in the forearm, passes through the carpal tunnel, and goes into the hand. Nine flexor tendons that bend the fingers and thumb also travel through the carpal tunnel. In CTS, thickening from the lining of irritated tendons or other swelling narrows the carpal tunnel and compresses the median nerve.

How Carpal Tunnel Syndrome Takes Shape

Carpal tunnel syndrome usually begins gradually with frequent burning, tingling, itching, or numbness in the palm and the fingers of a person’s dominant hand, especially the thumb and the index and middle fingers.3 Over time, grip strength may decrease, making it difficult to form a fist, grasp small objects, or perform other manual tasks. There is no single cause of CTS—it can be caused by trauma or injury to the wrist, rheumatoid arthritis, or fluid retention during pregnancy or menopause—but is most commonly caused by work stress, such as the repeated use of vibrating hand tools, assembly-line work, or even data-entry jobs.

In extreme cases of CTS, surgery may be the only remedy. But there are also some non-surgical treatments that may provide relief from symptoms:

  • Warm and Cold Therapy— CTS sufferers can ice their wrist or soak it in an ice bath for 10 to 15 minutes once or twice an hour until symptoms subside. Others may respond better to immersing their hand in warm water at a temperature between 92 and 100 degrees three to four times a day.
  • Nighttime Therapy— Symptoms often manifest themselves during the night, since many people sleep with flexed wrists. Nighttime pain may be relieved by gently shaking the hand and wrist or hanging the hand over the side of the bed. In addition, a cushioned resting splint explicitly made for nighttime use can keep people from flexing or overextending the wrist while they sleep.
  • Over-the-Counter Medication— Non-steroidal anti-inflammatory drugs such as ibuprofen or naproxen may help relieve pain and reduce inflammation. Certain creams applied topically can alleviate pain as well. Of course, one should always consult with a primary care physician to make sure these pain relievers do not react negatively with other medicines being taken.
  • Splints, Braces, and Supports— Rigid splints immobilize the wrist in a neutral to a slightly extended position, while allowing virtually unimpeded thumb and finger function. Specialized grip-fit splints control excessive wrist bending without restricting grip strength or interfering with grasp. Therapeutic gloves and compression sleeves can also reduce discomfort by providing support and promoting circulation in the hand and wrist.
  • Taking a Break— CTS sufferers should consider stopping the activity that is causing the compression. At the very least, it is always a good idea to take frequent breaks from any repetitive motion. Set a timer for 15 minutes and when it goes off, stop the activity, wiggle the fingers, stretch the hands, and move wrists to improve blood flow to these areas.

AliMed’s comprehensive line of carpal tunnel supports help limit and control unwanted motion while promoting daily activities.

Read more at alimed.com

References

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512